The first volunteer has received a dose in a first-in-human trial of Oxford's Lassa fever vaccine, a major milestone in ...

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially ...

To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially ...

‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...

Northern Ireland imposes a 20km control zone after suspected bluetongue case near Bangor, prompting movement bans and urgent farmer warnings.

The World Health Organisation (WHO) has identified Lassa fever as a priority pathogen in urgent need of research and ...

The Wellcome Photography Prize awards photographers who show how science affects human health around the world.

Clear communication across the UK and between vets and farmers is essential to manage Bluetongue virus (BTV) in Northern Ireland through vaccination and movement controls, says the National Sheep ...

The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries ...